Title : Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.

Pub. Date : 2017 Sep 8

PMID : 28886730






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells. Cisplatin mitogen-activated protein kinase 8 Homo sapiens
2 CONCLUSIONS: These data suggested that Annexin A2 induces cisplatin resistance of NSCLCs via regulation of JNK/c-Jun/p53 signaling, and provided an evidence that blockade of Annexin A2 could serve as a novel therapeutic approach for overcoming drug resistance in NSCLCs. Cisplatin mitogen-activated protein kinase 8 Homo sapiens